tipo
- journal article
The benefits of trastuzumab in the treatment of HER2+ breast cancer as a function of exposure time
Documento
- doi:10.3332/ecancer.2022.1347
- http://dx.doi.org/10.3332/ecancer.2022.1347
- http://https://doi.org/10.3332/ecancer.2022.1347
- http://https://ecancer.org/en/journal/article/1347-the-benefits-of-trastuzumab-in-the-treatment-of-her2-breast-cancer-as-a-function-of-exposure-time][doi:10.3332/ecancer.2022.1347
- http://https://ecancer.org/en/journal][doi:10.3332/ecancer.2022.1347
- Visão geral
- Identidade
- Informação adicional documento
- Outro
- Ver todos